Myasthenia Gravis

Latest News

Cell and gene therapies | Image Credit: © ArtemisDiana-stock.adobe.com
RNA CAR T Shows Promise for Myasthenia Gravis

September 3rd 2025

Long-term follow-up data on the use of BCMA-directed RNA chimeric antigen receptor T-cell therapy (CAR T) for refractory generalized myasthenia gravis show patient outcomes at 2, 3, 6, 9, and 12 months.

Myasthenia Gravis | Image Credit: © lexiconimages-stock.adobe.com
ADAPT SERON Trial Shows Positive Results for Seronegative gMG

August 28th 2025

glucocorticoid | Image Credit: © Vitalii Vodolazskyi-stock.adobe.com
Oral GC Dose Tapering for MG Linked to Efgartigimod Initiation

August 25th 2025

myasthenia gravis on a chalkboard | Image Credit: © Yurii Kibalnik-stock.adobe.com
MG Symptoms PRO Highlights Rozanolixizumab’s Impact on Fatigue, Weakness

August 22nd 2025

Myasthenia Gravis | Image Credit: © designua - stock.adobe.com
Nomogram Aids Early Detection of Myasthenic Crisis Risk

August 19th 2025

More News

Pills and book about myasthenia gravis | Image Credit: © mdaros - stock.adobe.com
December 17th 2024

Analysis Offers Insight Into Most Effective Treatment for MG

AJMC Contributor
Across treatments, rozanolixizumab and batoclimab were most effective, though rozanolixizumab carried increased risk of adverse events (AEs) and serious AEs.
MyastheniaGravis | Image Credit: ©syahrir-stock.adobe.com
December 7th 2024

Clinical Features Vary Across Myasthenia Gravis Foundation Classes

Karen Jacobson-Sive
Myasthenia Gravis Foundation of America (MGFA) class correlates with activities of daily living and other clinical characteristics on a group level, but individual variability is significant between patients of the same MGFA class.
Larynx model 3D | image credit: Matthieu - stock.adobe.com
December 3rd 2024

Laryngeal MG Is Best Diagnosed With a Tensilon Test or Pyridostigmine Bromide Trial

Karen Jacobson-Sive
Recent insights shed light onto the most effective diagnostic tools for laryngeal myasthenia gravis (MG), a poorly understood and often misdiagnosed condition, is most reliably.
Walking - kieferpix - stock.adobe.com.jpg
November 26th 2024

Analysis of Sleep, Exercise, and Symptoms Recommended for Optimal Myasthenia Gravis Care

Karen Jacobson-Sive
For some patients with myasthenia gravis (MG), activity and sleep were associated with reported fatigue and symptom levels.
Respiratory infections like COVID-19 are known to exacerbate MG | image credit: Cutie - stock.adobe.com
November 22nd 2024

COVID-19 Infection Raises Myasthenia Gravis Exacerbation Risk, Study Finds

Kimberly Rath, PharmD
A new study shows that COVID-19 infection significantly increases the risk of exacerbation in patients with myasthenia gravis (MG).
doctor and patient | Image Credit: © Halfpoint - stock.adobe.com
November 20th 2024

Understanding Patient Perspectives Around Myasthenia Gravis Treatment May Help Optimize Care

Karen Jacobson-Sive
Patients with myasthenia gravis (MG) largely expressed negative emotions around MG treatment and symptom burden in patient focus groups and on MG social media discussion boards.
Global health | Image Credit: © zephyr_p - stock.adobe.com
November 14th 2024

Worldwide Incidence, Prevalence of MG Has More Than Doubled Since 1950s

AJMC Contributor
The data come from a systematic review of over 90 studies between 1952 through 2022, which found that both prevalence and incidence rates have than doubled throughout the study period.
AI graphic | Image Credit: © NicoElNino-stock.adobe.com
November 8th 2024

Enhancing Myasthenia Gravis Care With AI-Powered Telemedicine

Kimberly Rath, PharmD
Researchers introduce a telemedicine system powered by artificial intelligence (AI) that automatically scores neuromuscular examinations, offering the potential to enhance patient monitoring, reduce variability in clinical trials, and improve access to care for neuromuscular disorders like myasthenia gravis.
Myasthenia gravis | Image Credit: © lexiconimages-stock.adobe.com
November 5th 2024

COVID-19 Exacerbations in Myasthenia Gravis Linked to Severity

Kimberly Rath, PharmD
This new study investigated the impact of COVID-19 on patients with myasthenia gravis, finding that although most patients did not experience severe COVID-19, a significant portion suffered postinfection exacerbations.
MG notes concept | image credit: Andrii - stock.adobe.com
October 23rd 2024

Rozanolixizumab Effective in Patients With MuSK MG, Analysis Shows

Jared Kaltwasser
A new subgroup analysis of patients with muscle-specific tyrosine kinase (MuSK) autoantibody-positive (Ab+) myasthenia gravis (MG) shows rozanolixizumab (Rystiggo) contributes to meaningful symptom improvement.
Colored Genetic Code DNA Molecule Structure | Image Credit: © ktsdesign - stock.adobe.com
October 16th 2024

Study Suggests Genetic Link Between HLA Alleles, MG

Gwen Mergian
Two genes were shown to be significantly associated with higher prevalence of myasthenia gravis (MG), a relatively rare autoimmune disease.
COVID-19 virus | Image credit: phonlamaiphoto - stock.adobe.com
October 6th 2024

Predictors of Poor Outcomes in Patients With Myasthenia Gravis and COVID-19

Kimberly Rath, PharmD
Researchers identify certain predictive factors that impact the prognosis of patients with myasthenia gravis and COVID-19 infection.
Thymus Gland | Image Credit: magicmine-stock.adobe.com
October 5th 2024

Small Study Shows Benefit With Minimally Invasive Thymectomy in MG

AJMC Contributor
Thoracoscopic thymectomy yielded quicker recovery time in myasthenia gravis (MG) while reducing disease severity, the need for treatment, and complications.
MG graphic | Image Credit: © Andrii-stock.adobe.com
October 2nd 2024

SC Efgartigimod Shows Noninferiority to IV Formulation in gMG

AJMC Contributor
The researchers have detailed their complete findings of subcutaneous (SC) vs intravenous (IV) efgartigimod in generalized myasthenia gravis (gMG) from the phase 3 ADAPT-SC trial and initial findings from the open-label extension of the study, ADAPT-SC+.
Statins may worsen myasthenic symptoms in MG | image credit: Ihphotos - stock.adobe.com
September 27th 2024

Statins Can Worsen MG Symptoms, but Cases Are Rare

Jared Kaltwasser
A study suggests most patients with myasthenia gravis (MG) can take statins without experiencing symptom worsening.
Myasthenia gravis | Image Credit: Andrii-stockk.adobe.com
September 24th 2024

Electrophysiology Aids Myasthenia Gravis, Related Disorders

Jared Kaltwasser
New research shows how repetitive nerve stimulation and single fiber electromyography can help diagnose disorders such as myasthenia gravis.
Image credit: luchschenF - stock.adobe.com
September 13th 2024

Researchers Characterize Distinct Biomarker Profile of AChR+ MG

AJMC Contributor
The potential value of these biomarkers may help differentiate acetylcholine receptor antibody seropositive (AChR+) myasthenia gravis (MG) from healthy patients.
A combination of infrared spectroscopy and AI could benefit the diagnosis of patients with MG | image credit: Tori Art - stock.adobe.com
September 6th 2024

Combining Infrared Spectroscopy, AI May Influence More Reliable Diagnosis of MG

AJMC Contributor
If integrated into clinical practice, the approach could fill a need for more optimal diagnostic approaches for myasthenia gravis (MG), explained the researchers.
New data make clear that there is a need for better diagnostic and disease-management strategies for myasthenia gravis. | Image credit: Николай Зотов - stock.adobe.com
August 31st 2024

Study: MG Diagnostic Delays Both Common and Harmful

Jared Kaltwasser
A survey of patients with myasthenia gravis in 5 European countries suggests patients wait on average about a year after symptom onset before they are given an accurate diagnosis.
Women typically experience more severe MG; however, this is not due to sex-based treatment differences | image credit: Wirestock - stock.adobe.com
August 24th 2024

No Sex-Based Differences Found in Treatment Timing in gMG

Gayle Turim Dickstein
A single-center cohort study found no differences between males and females in the odds of starting or time to treatment in generalized myasthenia gravis (gMG), but investigators want to continue to probe more deeply into why women are more severely affected by the disease.
concept of myasthenia gravis | Image Credit: syahrir-stock.adobe.com
August 17th 2024

Proximal Muscles Show Earlier RNS Response in MG, ALS

Karen Jacobson-Sive
The decremental response follows repetitive nerve stimulation (RNS) completed earlier in proximal muscles compared with distal muscles in a study of patients with myasthenia gravis (MG) and amyotrophic lateral sclerosis (ALS).
Patient in resp distress | Image Credit: New Africa-stock.adobe.com
August 13th 2024

Assessments Help Identify Patients With Myasthenia Gravis at Risk for Respiratory Distress

Karen Jacobson-Sive
A series of portable respiratory function tests for patients with mild to moderate myasthenia gravis (MG) were found to be useful methods to diagnose previously unidentified at-risk cases for respiratory deterioration.
Elderly patient lying in a hospital bed | Image credit: Soonthorn - stock.adobe.com
August 10th 2024

Pembrolizumab-Induced Overlap Syndrome: Case Report

Kimberly Rath, PharmD
A recent case report highlights the fatal risks of pembrolizumab, an immune checkpoint inhibitor, after an 87-year-old patient developed severe immune-related adverse events.
thymoma diagnosis | Image Credit: Vitalii Vodolazskyi-stock.adobe.com
August 7th 2024

Analysis Identifies Biomarkers in Thymoma-Associated MG

Jared Kaltwasser
The analysis represents an effort to use bioinformatics to find potential new therapeutic targets for myasthenia gravis (MG).
A woman consults with a doctor about myasthenia gravis symptoms. | Image credit: Chinnapong - stock.adobe.com
July 27th 2024

Analysis Supports Use of Newer PRO Scale in Myasthenia Gravis Trials

AJMC Contributor
A recent study showed that the Myasthenia Gravis (MG) Symptoms PRO scales viably measure core symptoms of the disease.
myasthenia gravis | Image Credit: Николай Зотов-stock.adobe.com
July 21st 2024

Chinese Patients With gMG Respond Well to Efgartigimod

Jared Kaltwasser
A new report offers safety and efficacy data on a population with generalized myasthenia gravis (gMG) not represented in the drug’s pivotal phase 3 trial.
Book about myasthenia gravis | Image Credit: mdaros-stock.adobe.com
July 16th 2024

Promising Results for Efgartigimod in Myasthenic Crisis

Kimberly Rath, PharmD
A new case report details the successful use of efgartigimod as a rescue medication in a patient with therapy-refractory myasthenic crisis.
Thymoma | Image Credit: Chris Titze Imaging - stock.adobe.com
July 11th 2024

Myasthenia Gravis: No Impact on Thymoma Outcome

Kimberly Rath, PharmD
A new study has found that myasthenia gravis does not affect the long-term prognosis of patients with thymoma.
Doctor speaking with patient | Image credit: Liudmila Dutko - stock.adobe.com
July 4th 2024

Treatment Patterns in Patients With Myasthenia Gravis Are Consistent Between US and Italy

Karen Jacobson-Sive
Patients with myasthenia gravis who received treatment within a year from diagnosis were generally in accordance with guideline suggestions.
Myasthenia gravis | Image Credit: © Andrii - stock.adobe.com
July 2nd 2024

Study Finds Ravulizumab Effective in Treating Acetylcholine Receptor–Positive Generalized MG

Karen Jacobson-Sive
More than 60% of complement inhibitor–naive patients with acetylcholine receptor–positive generalized myasthenia gravis (MG) in diverse clinical populations had a clinically meaningful reduction in MG activities of daily living scores.
<1234567>

259 Prospect Plains Rd, Bldg H,
Monroe, NJ 08831

© 2025 MJH Life Sciences® and AJMC®.
All rights reserved.

About
Contact
Editorial Boards
Advertise
Do Not Sell My Information
Terms & Conditions
Privacy Policy
AJMC Managed Markets Network Logo
CH LogoCenter for Biosimilars Logo